Einstein Experts for Media

Search Results

You searched for "HIV pathogenesis and HIV cure"

3 results found

Kartik Chandran, Ph.D.

Kartik Chandran, Ph.D.

Professor, Microbiology & Immunology

Harold and Muriel Block Faculty Scholar in Virology

COVID-19, Ebola, and emerging virusesAntibody-based therapiesAnti-viral therapeuticsVirus-host interactions

A recognized expert on emerging viruses, Dr. Chandran studies how viruses infect cells, and his research seeks to translate this knowledge into new antibody-based therapies. In 2020, Dr. Chandran helped lead Einstein’s research on COVID-19: Within weeks of the global outbreak, his laboratory created a “surrogate” coronavirus that allows scientists at Einstein and elsewhere to more safely study the virus. He also helped develop an antibody test for SARS-CoV-2 that is used clinically at Montefiore Health System and by researchers leading a convalescent plasma clinical trial. read more...

 

Jill P. Crandall, M.D.

Jill P. Crandall, M.D.

Professor, Department of Medicine (Endocrinology)

Jacob A. and Jeanne E. Barkey Chair in Medicine

Chief, Division of Endocrinology

Director, Fleischer Institute for Diabetes and Metabolism

DiabetesType 2 diabetesDiabetes prevention

Clinical TrialsPrediabetesResveratrol

An expert in diabetes prevention, Dr. Crandall is director of the Diabetes Clinical Trials Unit at Einstein and Montefiore and a principal investigator for several NIH-sponsored clinical trials, including the Diabetes Prevention Program Outcome Study (for which she holds several national leadership positions, including Executive Committee membership), Glycemia Reduction Approaches in Diabetes (GRADE) and the PERL (Preventing Early Renal Loss) study.  read more...

 

Harris Goldstein, M.D.

Harris Goldstein, M.D.

Professor, Department of Pediatrics (Pediatric Allergy & Immunology)

Professor, Department of Microbiology & Immunology

Associate Dean for Scientific Resources

Charles Michael Chair in Autoimmune Diseases

Director, Einstein-Rockefeller-CUNY Center for AIDS Research

HIV pathogenesis and HIV cure The immune system's antiviral activityEngineering molecules to attack virusesCAR-T cell structure and function Biologics against cancer and viruses

Dr. Goldstein’s NIH-funded research centers on developing agents to amplify the capacity of the immune system to control HIV infection and achieve a functional cure for the disease. In seeking to “weaponize” the immune system to cure HIV, his lab uses molecular, cellular, and biochemical approaches, including CAR-T cells and the novel treatment strategy developed by Dr. Almo at Einstein for selective T cell amplification called synTac (synthetic T-cell activation).  read more...